Publications en collaboration avec des chercheurs de Hospital of the University of Pennsylvania (31)

2024

  1. Clinical relevance of intracranial hemorrhage after thrombectomy versus medical management for large core infarct: a secondary analysis of the SELECT2 randomized trial

    Journal of NeuroInterventional Surgery, pp. 1-8

  2. Impact of COVID-19 on outcomes with teclistamab in patients with relapsed/refractory multiple myeloma in the phase 1/2 MajesTEC-1 study

    Blood Cancer Journal

  3. Teclistamab Improves Patient-Reported Symptoms and Health-Related Quality of Life in Relapsed or Refractory Multiple Myeloma: Results From the Phase II MajesTEC-1 Study

    Clinical Lymphoma, Myeloma and Leukemia, Vol. 24, Núm. 3, pp. 194-202

2023

  1. A Phase I/II Open-Label Study of Molibresib for the Treatment of Relapsed/Refractory Hematologic Malignancies

    Clinical cancer research : an official journal of the American Association for Cancer Research, Vol. 29, Núm. 4, pp. 711-722

  2. Efficacy and safety of cilta-cel in patients with progressive multiple myeloma after exposure to other BCMA-targeting agents

    Blood, Vol. 141, Núm. 3, pp. 219-230

  3. Ovarian cancer pathology characteristics as predictors of variant pathogenicity in BRCA1 and BRCA2

    British Journal of Cancer, Vol. 128, Núm. 12, pp. 2283-2294

2022

  1. Incidence and management of CAR-T neurotoxicity in patients with multiple myeloma treated with ciltacabtagene autoleucel in CARTITUDE studies

    Blood cancer journal, Vol. 12, Núm. 2, pp. 32

  2. Infective Endocarditis Caused by Staphylococcus aureus After Transcatheter Aortic Valve Replacement

    Canadian Journal of Cardiology, Vol. 38, Núm. 1, pp. 102-112

  3. Mitral Valve Infective Endocarditis after Trans-Catheter Aortic Valve Implantation

    American Journal of Cardiology, Vol. 172, pp. 90-97

  4. Perivalvular Extension of Infective Endocarditis After Transcatheter Aortic Valve Replacement

    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, Vol. 75, Núm. 4, pp. 638-646

  5. Surgical Treatment of Patients With Infective Endocarditis After Transcatheter Aortic Valve Implantation

    Journal of the American College of Cardiology, Vol. 79, Núm. 8, pp. 772-785

  6. Teclistamab in Relapsed or Refractory Multiple Myeloma

    New England Journal of Medicine, Vol. 387, Núm. 6, pp. 495-505

2021

  1. Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1

    Autophagy, Vol. 17, Núm. 1, pp. 1-382

  2. Strategy to prevent epitope masking in CAR.CD19+ B-cell leukemia blasts

    Journal for ImmunoTherapy of Cancer, Vol. 9, Núm. 6

  3. Stroke Complicating Infective Endocarditis After Transcatheter Aortic Valve Replacement

    Journal of the American College of Cardiology, Vol. 77, Núm. 18, pp. 2276-2287

  4. Teclistamab, a B-cell maturation antigen × CD3 bispecific antibody, in patients with relapsed or refractory multiple myeloma (MajesTEC-1): a multicentre, open-label, single-arm, phase 1 study

    The Lancet, Vol. 398, Núm. 10301, pp. 665-674

2020

  1. Clinical features associated with COVID-19 outcome in multiple myeloma: First results from the International Myeloma Society data set

    Blood, Vol. 136, Núm. 26, pp. 3033-3040

  2. Long-Term Outcomes After Infective Endocarditis After Transcatheter Aortic Valve Replacement

    Circulation, Vol. 142, Núm. 15, pp. 1497-1499

2019

  1. Guidelines for the use of flow cytometry and cell sorting in immunological studies (second edition)

    European Journal of Immunology, Vol. 49, Núm. 10, pp. 1457-1973

  2. Infective Endocarditis following Transcatheter Aortic Valve Replacement: Comparison of Balloon-Versus Self-Expandable Valves

    Circulation: Cardiovascular Interventions, Vol. 12, Núm. 11